Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$53.3 - $75.84 $60,229 - $85,699
-1,130 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$62.66 - $88.26 $939 - $1,323
15 Added 1.35%
1,130 $71,000
Q2 2021

Aug 12, 2021

BUY
$67.45 - $85.63 $337 - $428
5 Added 0.45%
1,115 $91,000
Q1 2021

May 13, 2021

SELL
$65.1 - $93.59 $976 - $1,403
-15 Reduced 1.33%
1,110 $81,000
Q4 2020

Feb 12, 2021

BUY
$48.36 - $77.92 $54,405 - $87,660
1,125 New
1,125 $81,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $1.87B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.